Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin

Cancer Letters

Volumn 161, Issue 2, 2000, Pages 231-240

  Hosaka, Yoshitaka ^a   Higuchi, Toshiyuki ^a   Tsumagari, Michiko ^a   Ishii, Hidemi ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Invasion; Metastasis; Thrombin; Thrombomodulin

Indexed keywords

HIRUDIN; IMMUNOGLOBULIN G; MATRIGEL; THROMBIN; THROMBOMODULIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER INVASION; CONCENTRATION RESPONSE; CONTROLLED STUDY; LUNG METASTASIS; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANIMALS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HIRUDINS; HUMANS; IMMUNOGLOBULIN G; LAMININ; LUNG NEOPLASMS; MELANOMA; MICE; NEOPLASM TRANSPLANTATION; PROTEOGLYCANS; PROTHROMBIN; THROMBIN; THROMBOMODULIN; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0034695191     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00617-0     Document Type: Article

References (42)

1. Tumor heterogeneity and the biology of cancer invasion and metastasis
2. Tumor invasion and metastasis: Role of the extracellular matrix: Rhoads memorial award lecture
3. Basement membrane and the invasive activity of metastatic tumor cells
4. Platelet contribution to the formation of metastatic foci: The role of cancer cell-induced platelet activation
5. Interaction of tumor cells with vascular endothelial cell monolayers: A model for metastatic invasion
6. Role of platelet membrane in enhancement of tumor cell adhesion to endothelial cell extracellular matrix
7. The roles of protein C and thrombomodulin in the regulation of blood coagulation
8. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation
9. Human thrombomodulin: Complete cDNA sequence and chromosome localization of the gene
10. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity
11. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity
12. Thrombomodulin is present in human plasma and urine
13. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells
14. Characterization of soluble thrombomodulin fragments in human urine
15. Purification and characterization of two form of soluble TM from human urine
16. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo
17. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: Comparison with low molecular weight heparin
18. 4-3GlcAβ1-3Galβ1-3(+/-Siaα2-6)Galβ1-4Xyl
19. Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin
20. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
21. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B
22. Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinoma
23. Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc
24. An immunohistochemical study of thrombomodulin in oral squamous cell carcinoma and its association with invasive and metastatic potential
25. Thrombomodulin is a new biological and prognostic marker for breast cancer: An immunohistochemical study
26. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies
27. Presence and function of chondroitin-4-sulfate on recombinant human soluble thrombomodulin
28. The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for swiss 3T3 cells
29. A rapid in vitro assay for quantitating the invasive potential of tumor cells
30. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells
31. Ligand specificity of human thrombomodulin
32. Prothrombin activator from Echis carinatus venom
33. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis
34. Plasmodium falciparum-infected erythrocytes: A mutational analysis of cytoadherence via murine thrombomodulin
35. Preparation of lipid-derivatized glycosaminoglycans to probe a regulatory function of the carbohydrate moieties of proteoglycans in cell-matrix interaction
36. Inhibition of experimental metastasis and cell adhesion of murine melanoma cells by chondroitin sulfate-derivatized lipid, a neoproteoglycan with anti-cell adhesion activity
37. Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and function assays
38. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis
39. Blood coagulation activation in cancer: Challenges for cancer treatment
40. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor
41. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells
42. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes